Medicamen Biotech Share price

Q: How to buy Medicamen Biotech Share at Choice?

To buy Medicamen Biotech stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Medicamen Biotech, choose your preferred order type, and place the trade.

MEDICAMEQ

Healthcare Small Cap

271.8

6.25 (-2.25%)

NSE

BSE

Last updated on 14 May, 2026 | 15:56 IST

BUYSELL

Today's High

294.05

Today's Low

268.10

52 Week Low

216.95

52 Week High

455.95

Free Demat with Zero AMC*

Medicamen Biotech Chart

ChartIQ

TradingView

Medicamen Biotech Share Key Metrics

Volume

37047.00

Market Cap

368.64 CR

LTQ@LTP

100@271.80

ATP

281.01 Var Margin

100 %

Circuit Range

222.45-333.65

Delivery %

26.47 %

Value

1.04 CR

ASM/GSM

No

Market Lot

1

Summary

Medicamen Biotech share price is ₹271.8 as of 15 May, 2026. The stock Medicamen Biotech intraday movement has stayed between ₹268.10 and ₹294.05, while on a 52-week basis,Medicamen Biotech price 52 week high is ₹455.95 & its 52 week low is ₹216.95.

In terms of trading activity, Medicamen Biotech has recorded a volume of 37047 shares, The Medicamen Biotech has a market cap of ₹13562815 CR. The stock’s Average Traded Price (ATP) stands at ₹281.01, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100 @ ₹271.80.

Medicamen Biotech operates within a circuit range of ₹222.45 – ₹333.65, with a Value of ₹1.04 CR. The Delivery Percentage for the day is 26.47%. Additionally, Medicamen Biotech currently falls under the No framework, and trades with a market lot size of 1.

Medicamen Biotech Fundamentals

P/E Ratio

39.88

P/B Ratio

1.39

Div. Yield

0.36

Sector P/E

66.86

Sector P/B

3.47

Sec. Div. Yield

0.56

Medicamen Biotech Resistance and Support

Pivot 279.17

Resistance

First Resistance

284.34

Second Resistance

290.62

Third Resistance

295.79

Support

First Support

272.89

Second Support

267.72

Third Support

261.44

Medicamen Biotech Shareholding Pattern

2024-25
2023-24
2025-26
2022-23
2021-22
2020-21
2019-20
2018-19
2016-17
2026-27

Total Promoters

Segment

Percent

Total Promoters

40.46%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.1%

Domestic Institutional Investors

0.05%

Retail

59.39%

Others

0%

Total Promoters

MAR '26

40.46%

Medicamen Biotech Corporate Actions

Date	Agenda
2026-02-13	Quarterly Results
2025-11-14	Quarterly Results
2025-08-12	Quarterly Results
2025-05-30	Audited Results & Final Dividend
2025-02-26	Preferential issue of shares
2025-02-11	Quarterly Results

Medicamen Biotech News

About Medicamen Biotech

NSE : 6278

BSE : 531146

ISIN : INE646B01010

MBL was incorporated as a public limited company under the Companies Act 1956 on December 22 1993. The certificate of commencement of business was obtained on January 31 1994. The company has jointly been promoted by Mr.V.Kumar Mr.Bal Kishan Gupta Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh.MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst Cadila Hindustan Ciba Purepharma Oboi Labs etc. and exporting to countries like Germany Russia Holland CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales.MBL has obtained permission for production of tablets capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited New Delhi and Pure Pharma Private Limited Indore respectively.

Name	Position
Rahul Bishnoi	Chairman
Vimal Kumar Shrawat	Non Independent & Non Executive Director

Medicamen Biotech Similar Stocks

Valiant Laboratories Ltd.

79.39

-0.39 (0.49%)

Nephro Care India Ltd.

79.35

-0.20 (0.25%)

Par Drugs And Chemicals Ltd.

92.64

-0.37 (0.40%)

Kaya Ltd.

243.60

-0.25 (0.10%)

Bafna Pharmaceuticals Ltd.

135.90

-2.70 (1.95%)

Medicamen Biotech FAQs

The Buying Price of Medicamen Biotech share is 271.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Medicamen Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Medicamen Biotech, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Medicamen Biotech shares is 39.88. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Medicamen Biotech shares is 1.39. Useful to assess the stock's value relative to its book value.

To assess Medicamen Biotech’s valuation compare Sector P/E, P/B which are 66.86 & 3.47 with sector averages, along with growth rates and financial metrics.

The Market Cap of Medicamen Biotech is 368.64 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Medicamen Biotech share price is 455.95 & 216.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Medicamen Biotech belongs to the Healthcare sector.